Some of the earliest studies into steroid hormone action clearly showed that steroids could bind to specific, high-affinity binding sites (or receptors) localized on surface-membrane fractions of their target cells (Pietras and Szego, 1977) . However, other laboratories demonstrated the presence of specific steroid receptors in the nuclear-cytosolic fractions of target cells and showed that such receptors could act as ligand-dependent transcription factors capable of modulating the activity of specific genes that were known to be regulated by steroid hormones. These findings led, understandably, to the concentration of effort on elaborating the classical genomic steroid hormone actions. However, there has been a recent resurgence of interest in the actions of steroids at the cell surface membrane, and a growing realization that some effects of steroid hormones clearly cannot be explained by a change in transcription (Table 1) . A number of excellent reviews have appeared in the last few years that discuss in detail non-genomic effects of progesterone (Sutter-Dub, 2002 ) and other Email: tbramley@staffmail.ed.ac.uk steroids (Wehling, 1997; Revelli et al., 1998; Falkenstein et al., 2000a; Schmidt et al., 2000; Kelly and Levine, 2001) .
Progesterone is an important intermediate in the synthesis of androgens and oestrogens. It plays an important role in ovulation, atresia and luteinization in vivo (Telleria and Deis, 1994; Chaffin and Stouffer, 2000) , and is essential for the continuation of early pregnancy in all mammalian species. However, the importance of genomic and non-genomic responses to progesterone in the mammalian ovary is still being debated. Some of the issues addressed in this review are:
r Which responses to progesterone are mediated through classical genomic effects, non-classical genomic or non-genomic actions? 
Classical genomic progesterone receptors
The genomic progesterone receptor is a member of the ligand-inducible DNA-binding superfamily of nuclear transcription factors that includes the receptors for the other steroid hormones, thyroid hormones, vitamin D, retinoic acid and a variety of 'orphan' receptors. The cDNA for the B-form of the (human) genomic progesterone receptor (gPR-B) consists of eight different exons separated by seven short introns, and codes for a 933 amino acid (116 kDa) protein containing a number of different functional domains (Fig. 1) . Exon 1 codes for the N-terminal region of the receptor and for one of three activation function domains (AF-3). Exons 2 and 3 code for AF-1 and the DNA-binding domain (DBD) with its two zinc fingers. Exons 4-8 code for the ligand-binding domain (LBD) and AF-2. This region also codes for the hinge region, a nuclear localization signal (NLS), and regions important for receptor dimerization and binding of heat-shock proteins and immunophilins. Two other isoforms of the human gPR arise from the use of alternate promoters within the same gene. PR-A is N-terminally truncated (94 kDa), lacking 164 amino acids containing the AF-3 domain (Giangrande and McDonnell, 1999) , whereas PR-C (60 kDa) lacks exon 1 and most of exon 2 (Wei and Miner, 1994) .
Several other variants of gPR have been described (Fig. 1) . One variant codes for a protein that lacks the NLS, hinge region and part of the LBD; another variant has a frameshift that gives rise to a truncated protein lacking much of the LBD (Hodges et al., 1999) . In addition, other PR variants have been described that have deletions of one or more exons (Misao et al., 1998a; 2000) or that have previously unidentified 5 sequences spliced to novel exons, yet still retain those exons (exons 4-8) that code for the LBD (Hirata et al., 2000 (Hirata et al., , 2002 . Variants lacking the LBD or DBD can modify the effects of fulllength wild-type gPR-B (Vegeto et al., 1993; Wei et al., 1997; Hodges et al., 1999; Misao et al., 2000) .
Effects of progesterone and anti-gestagens on ovarian function: classical genomic, non-classical genomic or non-genomic effects?
Some of the known responses of ovarian tissues to progesterone in vitro are listed for domestic animals (Table  2) , humans and primates (Table 3) and rats (Table 4) . Both the dose-response characteristics and sensitivity to anti-progestins of rapid and longer-term responses are distinct. Stimulation of intracellular Ca 2+ and inositol trisphosphate (IP 3 ) (and protein kinase C ␤1 (PKC-␤1)) by progesterone is detectable within seconds at picomolar levels and is not blocked by anti-gestagens. In general, longer-term actions (effects on steroidogenesis, apoptosis and proliferation; activation of protein or mRNA synthesis) are detectable only at much higher (nanomolar to micromolar) concentrations of progesterone, and are reversed by anti-gestagens (Tables 2-4) , implying action via classical genomic progesterone receptors. To date, rapid Ca 2+ , IP 3 , phospholipase C-␤ (PLC-␤) responses have been studied only in pig granulosa cells, although similar rapid and specific responses to androgen and oestrogen have also been observed in pig granulosa cells (Lieberherr et al., 1999) and to other steroids in cells lacking classical steroid receptors (Le Mellay et al., 1999) . Whether rapid response to very low progesterone concentrations is a general response in the ovarian cells of other mammalian species is still unclear.
The actions of progesterone and synthetic progestagens may differ (for review, see Swan et al., 2002 
Ovarian genomic progesterone receptors
The presence and cellular localization of gPR proteins and mRNA in ovarian tissues has been demonstrated by immunocytochemistry and in situ hybridization (Tables 5  and 6 ). Most of these studies have used antibodies and primers designed to detect either the ligand binding domain (LBD) of the gPR, or the N-terminus (to differentiate PR-A and PR-B isoforms). PR-A and PR-B have been localized simultaneously in the same types of cell (Mote et al., 1999) . It will be of interest to examine the distribution of PR-A and PR-B isoforms in types of ovarian cell at different stages of the ovarian cycle, and to study their responses to luteotrophic and luteolytic stimuli.
The co-expression of PR-A or PR-C in the same type of cell as PR-B modulates its activity (Vegeto et al., 1993; Wei et al., 1997) . Moreover, genomic actions of progesterone receptor isoforms are affected differentially by their association with chaperones (Smith, 2000) and nuclear coactivators (Rowan and O'Malley, 2000) , and are modulated by receptor phosphorylation (Orti et al., 1992) and by cross-talk with other signalling pathways (mitogen-activated protein kinase (MAPK), Src, tyrosine kinases, phosphatidyl inositol 3-kinase (PI3-K)) that are activated by growth factors and cytokines (Richer et al., 1998; Boonyaratanakornkit et al., 2001; Bagowski et al., 2001) . Furthermore, gPRs can exist in different functional states (Smith et al., 2000) , and can exhibit direct nongenomic actions in their unliganded (Weigel and Zhang, 1998) and undimerized states (Cohen-Solal et al., 1993) . Finally, PR-A and PR-B isoforms can activate different constellations of genes even within the same cell (Richer et al., 2002) , highlighting the enormous complexity of the intracellular processes involved in progesterone activation of a target cell.
Non-genomic membrane receptors for progesterone
Steroids can affect membrane-mediated events nongenomically in a number of ways (for example, by effects on membrane fluidity, or by direct effects on other G-protein-coupled receptors; for review, see Falkenstein et al., 2000b) . However, studies of rapid, steroid-specific responses to progesterone, mediated by the cell membrane, culminated in the isolation and cloning of a non-genomic (pig) progesterone receptor of 194 amino acids, with a single membrane-spanning domain (Falkenstein et al., 1996; Meyer et al., 1996) . Homologous proteins were subsequently cloned in rats (Selmin et al., 1996; Krebs et al., 2000; Nolte et al., 2000) and cattle (Cenedella et al., 1999; Zhu et al., 2001) , and two putative mPR homologues (hpr6.6 and Dg6) were identified in humans (Gerdes et al., 1998) . The human mPR gene consists of three exons separated by two introns. The 5 -region lacks a typical TATA box, but has high homology to a transcription initiator consensus sequence. The proximal region is GC-rich, and a CpG island spans the putative transcription start site (Bernauer et al., 2001) . Several upstream regulatory DNA motifs were identified, including AP2, NF-AT, C/EBP and Ahr/Arnt (Bernauer et al., 2001) .
Although the rapid effects of progesterone are mediated at the cell surface membrane of a variety of types of cell in pig hepatocytes (Falkenstein et al., 1998) and in Chinese hamster ovary cells transfected with mPR (Falkenstein et al., 1999) , progesterone binding is associated with the endo-membrane rather than the cell surface-membrane fraction. Nevertheless, the protein was exposed at the cell surface of human spermatozoa, as an antibody to the protein prevented induction of the acrosome reaction by progesterone, but not by other agonists (Falkenstein et al., 1999; Buddhikot et al., 1999) .
What is the nature of the membrane receptor for progesterone?
There is conflicting data on the nature of the membrane progesterone receptor, and the signalling pathways used in different types of cell (Fig. 2) . Studies of rapid, membrane-mediated events in several types of cell have identified a wide range of changes, including Ca 2+ mobilization (influx or mobilization from intracellular stores), opening of Na + and Cl − channels, and the activation of phospholipase C (leading to increased intracellular IP 3 and diacylglycerol generation), Pertussis toxin-insensitive G-protein-coupled receptors, PKC, tyrosine kinase and MAPK pathways (for review, see Wehling, 1997; Falkenstein et al., 2000a) . However, it is unclear which of these changes are primary, and which are activated by other downstream events or by cross-talk with other signalling pathways. Although the rat ovarian mPR has some similarity to gamma amino butyric acid A receptors (GABA A ) (Peluso and Pappalardo, 1998), GABA agonists and antagonists failed to affect progesterone binding to bovine luteal membranes (Menzies et al., 1999) .
The two most widely used models for studies of the non-genomic progesterone receptor are human spermatozoa (which had been thought to lack the genomic PR; Castilla et al., 1995) and the Xenopus oocyte (in which responses in enucleated cells, and membraneimpermeable derivatives of progesterone can mimic all the rapid changes induced by the steroid). However, doubts about these models have been raised as (a) spermatozoa appear to contain small amounts of gPR mRNA (Sachdeva et al., 2000; Contreras and Llanos, 2001), and (b) cloning of the receptor responsible for inducing oocyte maturation (xPR) has revealed it to be similar to the mammalian genomic progesterone receptor (Maller, 2001) . xPR associates with p42 MAPK and activates oocyte maturation non-classically by signalling through the PI3-K pathway (Bagowski et al., 2001) . Studies designed to identify and localize progesterone receptors in ovarian tissues have often used antibodies to the LBD of the gPR (Tables 5 and 6 ). However, antibodies raised to other regions of the gPR often give little or no signal in these same tissues (for review, see Press and Greene, 1988; El-Hefnawy et al., 2000; Luconi et al., 1998 -but see Luconi et al., 2002 . Furthermore, a commonly used monoclonal antibody raised to the C-terminal end of the gPR (mAb C262) also detects immunoactivity in isolated rat granulosa cell membranes (Peluso and Pappalardo, 1998, 1999; Peluso et al., 2001) and in bovine luteal membranes and detergent extracts (Bramley et al., 2002) , indicating that the membrane steroid receptor may possess a domain with homology to the LBD of the gPR. Indeed, different methods of detecting mPR can identify proteins of markedly different sizes even in the same tissues and species (for review, see Bramley et al., 2002) . Finally, it will be of interest to establish whether gPR variants with deleted exons or novel 5 -regions (vide infra) are present in tissues with high amounts of membrane progesterone binding sites and, if so, to study their subcellular distribution at different stages of ovarian development and functional activity.
Conclusion
Progesterone can induce rapid and specific changes in a variety of tissues by acting via membrane-associated receptors. However, the nature of these receptors is presently unclear. Although membrane-associated, progesterone-specific receptors have been isolated and cloned from a range of tissues in a number of species, the protein isolated appears to be only one subunit of the (possibly dimeric) membrane receptor, and it has been difficult to demonstrate binding to the expressed protein. However, other studies indicate a membrane protein (or an associated protein) with homology to the ligand-binding domain of the genomic progesterone receptor. Further studies of these receptors in the ovary, and the ways in which they interact with other autocrine or paracrine factors, may lead to exciting advances in the understanding of the progesterone-dependent processes of ovulation, luteinization, follicular atresia and maternal recognition of pregnancy, and so permit the development of new methods of manipulating ovarian activity and fertility in humans and other mammalian species. 
